Goldmann L, Duan R, Kragh T, Et Al. Oral Bruton Tyrosine Kinase Inhibitors Block Activation of the Platelet Fc Receptor CD32a (FcγRIIA): A New Option in HIT? Blood Adv. 2019;3(23):4021-4033.

Blood advances - United States
doi 10.1182/bloodadvances.2019001362
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors

Unknown

Publisher

American Society of Hematology


Related search